Table 3 Factors associated to the presence of IMIDs: differences between Crohn’s disease and ulcerative colitis.

From: Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach

 

UC with IMID associated (%, n)

Odds ratio (95% CI)

CD with IMID associated (%, n)

Odds ratio (95% CI)

Gender (Women)

61.1 (105)

1.73 (1.22–2.45)

52.2 (105)

1.26 (0.9–1.75)

Familiar history (yes)

3.5 (6)

0.64 (0.27–1.55)

9.0 (18)

1.17 (0.66–2.1)

Tobacco (smoker vs. no smoker)

10.7 (16)

1.19 (0.65–2.19)

28.9 (52)

1.19 (0.83–1.69)

Complications (yes)

1.2 (2)

1.22 (0–5.5)

14.2 (27)

1.1 (0.68–1.8)

Immunomodulator therapy (yes)

33.1 (57)

1.82 (1.25–2.66)

62.2 (125)

1.26 (0.9–1.77)

Biological therapy (yes)

23.3 (40)

2.16 (1.4–3.34)

47.8 (96)

1.59 (1.14–2.22)

Surgery (yes)

7.0 (12)

1.5 (0.75–3.04)

34.3 (69)

0.86 (0.61–1.21)